CLASS II ONGOING Drug recall · Reported 21 Oct 2026 · FDA Enforcement Report

Hydrocortisone Sodium Succinate for Injection recalled

Zydus Pharmaceuticals is recalling Hydrocortisone Sodium Succinate for Injection, USP 100 mg/vial, 1 Vial, distributed nationwide in the US. The recall was initiated on 1 Oct 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: LB00047A, LB00048A, Exp. Date 03/2028
NDC70710-1907
Quantity recalled70776 vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0039-2027
FDA event ID
100017
Recalling firm
Zydus Pharmaceuticals, Pennington, NJ
Manufacturer
Zydus Pharmaceuticals USA Inc.
Classification
Class II
Status
Ongoing
Recall initiated
1 Oct 2026
FDA classified
13 Oct 2026
Reported
21 Oct 2026
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

1 Oct 2026Recall initiated by company
13 Oct 2026Classified by FDA+12 days
21 Oct 2026Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Impurities/Degradation Specifications.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Hydrocortisone Sodium Succinate for Injection, USP 100 mg/vial, 1 Vial, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Vadodara - 391510 India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1907-1.

Where it was distributed

Nationwide within the United States

Nationwide

Questions about this recall

Why was it recalled?

Failed Impurities/Degradation Specifications.

Which lots are affected?

Lot #: LB00047A, LB00048A, Exp. Date 03/2028

Where was it sold?

Nationwide within the United States

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 27 Oct 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Zydus Pharmaceuticals

All 55

Other Hydrocortisone recalls

All 25